AU2008266885A1 - Treatment of diseases and disorders using self-renewing colony forming cells cultured and expanded in vitro - Google Patents
Treatment of diseases and disorders using self-renewing colony forming cells cultured and expanded in vitro Download PDFInfo
- Publication number
- AU2008266885A1 AU2008266885A1 AU2008266885A AU2008266885A AU2008266885A1 AU 2008266885 A1 AU2008266885 A1 AU 2008266885A1 AU 2008266885 A AU2008266885 A AU 2008266885A AU 2008266885 A AU2008266885 A AU 2008266885A AU 2008266885 A1 AU2008266885 A1 AU 2008266885A1
- Authority
- AU
- Australia
- Prior art keywords
- cells
- tissue
- bone marrow
- disease
- damage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0669—Bone marrow stromal cells; Whole bone marrow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1722—Plasma globulins, lactoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Marine Sciences & Fisheries (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2013202319A AU2013202319A1 (en) | 2007-06-15 | 2013-04-03 | Treatment of diseases and disorders using self-renewing colony forming cells cultured and expanded in vitro |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92915107P | 2007-06-15 | 2007-06-15 | |
| US92915207P | 2007-06-15 | 2007-06-15 | |
| US60/929,152 | 2007-06-15 | ||
| US60/929,151 | 2007-06-15 | ||
| US95520407P | 2007-08-10 | 2007-08-10 | |
| US60/955,204 | 2007-08-10 | ||
| US99609307P | 2007-11-01 | 2007-11-01 | |
| US60/996,093 | 2007-11-01 | ||
| PCT/US2008/007488 WO2008156728A1 (en) | 2007-06-15 | 2008-06-16 | Treatment of diseases and disorders using self-renewing colony forming cells cultured and expanded in vitro |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2013202319A Division AU2013202319A1 (en) | 2007-06-15 | 2013-04-03 | Treatment of diseases and disorders using self-renewing colony forming cells cultured and expanded in vitro |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2008266885A1 true AU2008266885A1 (en) | 2008-12-24 |
Family
ID=40156544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2008266885A Abandoned AU2008266885A1 (en) | 2007-06-15 | 2008-06-16 | Treatment of diseases and disorders using self-renewing colony forming cells cultured and expanded in vitro |
Country Status (14)
| Country | Link |
|---|---|
| US (5) | US8354370B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2171043B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2010529987A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20100035648A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101835891A (cg-RX-API-DMAC7.html) |
| AP (1) | AP2010005103A0 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2008266885A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2690143A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO6251330A2 (cg-RX-API-DMAC7.html) |
| EA (1) | EA201070022A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL202445A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2009013672A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ582616A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2008156728A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9969980B2 (en) | 2001-09-21 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
| US9969977B2 (en) * | 2002-09-20 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
| US8354370B2 (en) | 2007-06-15 | 2013-01-15 | Garnet Biotherapeutics, Inc. | Administering a biological composition or compositions isolated from self-renewing colony forming somatic cell growth medium to treat diseases and disorders |
| WO2010117198A2 (ko) * | 2009-04-06 | 2010-10-14 | 영남대학교 산학협력단 | 성별 특이적 혈청의 제조방법 및 이를 이용한 바이오마커 |
| JP2013528175A (ja) * | 2010-05-28 | 2013-07-08 | ガーネット バイオセラピューティクス インコーポレイテッド | インビトロで培養し、増殖させた自己複製コロニー形成細胞由来の成分を有する、生存しているおよび生存していない生理活性デバイスの組成物ならびにそれらの使用法 |
| EP2554662A1 (en) * | 2011-08-05 | 2013-02-06 | M Maria Pia Cosma | Methods of treatment of retinal degeneration diseases |
| KR101548124B1 (ko) * | 2011-10-04 | 2015-08-31 | (주) 메디컬그룹베스티안 | 피부결함의 완화 또는 치료를 위한 세포처리 및 적용 시스템 |
| US10016458B2 (en) | 2012-04-16 | 2018-07-10 | Baystate Health, Inc. | p53 silenced endothelial progenitor cells for diabetes |
| US20140134732A1 (en) * | 2012-11-14 | 2014-05-15 | Wisconsin Alumni Research Foundation | Simplified Compositions and Methods for Generating Neural Stem Cells From Human Pluripotent Stem Cells |
| GB201513996D0 (en) | 2015-08-07 | 2015-09-23 | Cell Therapy Ltd | Immuno-oncology mesodermal progenitor (IOMP) cell |
| US11253630B2 (en) | 2016-04-22 | 2022-02-22 | Vivex Biologics Group, Inc. | Malleable demineralized bone composition and method of manufacture |
| US11253629B2 (en) | 2016-04-22 | 2022-02-22 | Vivex Biologics Group, Inc. | Bone gel sheet composition and method of manufacture |
| US9788950B1 (en) | 2016-04-22 | 2017-10-17 | Vivex Biomedical, Inc. | Cohesive bone composition |
| US10596298B2 (en) | 2016-04-22 | 2020-03-24 | Vivex Biologics Group, Inc. | Malleable demineralized bone composition and method of manufacture |
| US10463767B2 (en) | 2016-04-22 | 2019-11-05 | Vivex Biologics Group, Inc. | Moldable bone composition |
| WO2018187786A1 (en) * | 2017-04-07 | 2018-10-11 | La Jolla Institute For Allergy And Immunology | Unipotent neutrophil progenitor cells, methods of preparation, and uses thereof |
| CN109251885A (zh) * | 2018-09-26 | 2019-01-22 | 北京添易医学研究院 | 医美级胎盘基蜕膜干细胞内液的制备方法 |
| CN111394306B (zh) * | 2020-04-15 | 2023-08-01 | 深圳市旷逸生物科技有限公司 | 一种提高脐带间充质干细胞的体外扩增速率的培养方法 |
| CN114591910B (zh) * | 2022-03-28 | 2023-11-21 | 重庆市铂而斐细胞生物技术有限公司 | 一种利用低氧三维环境培养的间充质干细胞富集脐血造血干细胞的方法 |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1168205B (it) | 1983-07-21 | 1987-05-20 | Wellcome Italia | Derivato di monsialo ganglioside dotato di attivita' antibatterica, antifungina ed antitumorale, composizioni che lo contengono e procedimento per la loro preparazione |
| US4608199A (en) | 1984-03-20 | 1986-08-26 | Arnold Caplan | Bone protein purification process |
| US4609551A (en) | 1984-03-20 | 1986-09-02 | Arnold Caplan | Process of and material for stimulating growth of cartilage and bony tissue at anatomical sites |
| US4620327A (en) | 1984-07-05 | 1986-11-04 | Caplan Arnold I | Process of adapting soluble bone protein for use in stimulating osteoinduction |
| US5744347A (en) * | 1987-01-16 | 1998-04-28 | Ohio University Edison Biotechnology Institute | Yolk sac stem cells and their uses |
| US5061620A (en) | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
| US6010696A (en) | 1990-11-16 | 2000-01-04 | Osiris Therapeutics, Inc. | Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells |
| US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| US5837539A (en) | 1990-11-16 | 1998-11-17 | Osiris Therapeutics, Inc. | Monoclonal antibodies for human mesenchymal stem cells |
| US5811094A (en) | 1990-11-16 | 1998-09-22 | Osiris Therapeutics, Inc. | Connective tissue regeneration using human mesenchymal stem cell preparations |
| US5226914A (en) | 1990-11-16 | 1993-07-13 | Caplan Arnold I | Method for treating connective tissue disorders |
| US5733542A (en) | 1990-11-16 | 1998-03-31 | Haynesworth; Stephen E. | Enhancing bone marrow engraftment using MSCS |
| US5197985A (en) | 1990-11-16 | 1993-03-30 | Caplan Arnold I | Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells |
| US5591625A (en) | 1993-11-24 | 1997-01-07 | Case Western Reserve University | Transduced mesenchymal stem cells |
| US6719972B1 (en) | 1994-06-03 | 2004-04-13 | Repligen Corporation | Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA4- specific antibodies |
| US6174333B1 (en) | 1994-06-06 | 2001-01-16 | Osiris Therapeutics, Inc. | Biomatrix for soft tissue regeneration using mesenchymal stem cells |
| ES2206509T3 (es) | 1994-06-06 | 2004-05-16 | Case Western Reserve University | Biomatriz para la regeneracion de tejidos. |
| US5736396A (en) | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
| US5643736A (en) | 1995-02-06 | 1997-07-01 | Osiris Therapeutics, Inc. | Monoclonal antibodies for human osteogenic cell surface antigens |
| US5716616A (en) | 1995-03-28 | 1998-02-10 | Thomas Jefferson University | Isolated stromal cells for treating diseases, disorders or conditions characterized by bone defects |
| US6653134B2 (en) | 1995-03-28 | 2003-11-25 | Cp Hahnemann University | Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| US6974571B2 (en) | 1995-03-28 | 2005-12-13 | Thomas Jefferson University | Isolated stromal cells and methods of using the same |
| US5728581A (en) | 1995-06-07 | 1998-03-17 | Systemix, Inc. | Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein |
| CN1209836A (zh) | 1995-12-29 | 1999-03-03 | 阿尔格公司 | 骨髓基质细胞的扩展 |
| US5811297A (en) * | 1996-03-07 | 1998-09-22 | Amba Biosciences, Llc | Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, & in vitro generation of dendritic cells and macrophages |
| US6368636B1 (en) * | 1998-03-18 | 2002-04-09 | Osiris Therapeutics, Inc. | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| EP1096941B1 (en) | 1998-05-07 | 2005-08-10 | University Of South Florida | Bone marrow cells as a source of neurons for brain and spinal cord repair |
| CA2348770A1 (en) | 1998-10-26 | 2000-05-04 | Philadelphia Health & Education Corporation | Stromal cell use |
| US6184035B1 (en) | 1998-11-18 | 2001-02-06 | California Institute Of Technology | Methods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cells |
| US20030003572A1 (en) | 1999-03-05 | 2003-01-02 | David J. Anderson | Isolation and enrichment of neural stem cells from uncultured tissue based on cell-surface marker expression |
| AU780994B2 (en) | 1999-05-14 | 2005-04-28 | Henry Ford Health System | Bone marrow transplantation for treatment of stroke |
| US6226914B1 (en) * | 1999-06-25 | 2001-05-08 | Waymon Burton Reed | Firearm safety apparatus |
| AUPQ147799A0 (en) | 1999-07-07 | 1999-07-29 | Medvet Science Pty. Ltd. | Mesenchymal precursor cell |
| EP1226233B1 (en) | 1999-08-05 | 2011-06-29 | ABT Holding Company | Multipotent adult stem cells and methods for isolation |
| US7015037B1 (en) | 1999-08-05 | 2006-03-21 | Regents Of The University Of Minnesota | Multiponent adult stem cells and methods for isolation |
| US8075881B2 (en) | 1999-08-05 | 2011-12-13 | Regents Of The University Of Minnesota | Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure |
| AU7611500A (en) | 1999-09-24 | 2001-04-24 | Abt Holding Company | Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
| EP1227825A4 (en) | 1999-10-29 | 2003-07-02 | Philadelphia Health & Educatio | Isolation and expansion of human marrow stromal cells |
| FR2801979B1 (fr) | 1999-12-03 | 2002-02-08 | Oreal | Utilisation d'un anticorps specifique des fibroblastes papillaires comme marqueur de qualite d'une peau |
| US7544509B2 (en) | 2000-01-24 | 2009-06-09 | Mcgill University | Method for preparing stem cell preparations |
| AU3685401A (en) | 2000-02-11 | 2001-08-20 | Philadelphia Health | Differentiation of bone marrow cells into neuronal cells and uses therefor |
| AU2001246894A1 (en) | 2000-04-11 | 2001-10-23 | Kyowa Hakko Kogyo Co. Ltd. | Alpha1,2-fucosyltransferase and process for producing fucose-containing complex carbohydrate |
| JP2004511266A (ja) | 2000-04-12 | 2004-04-15 | チルドレンズ ホスピタル オブ フィラデルフィア | 間葉間質細胞に対する治療的利用法 |
| AU2001285359A1 (en) | 2000-09-01 | 2002-03-13 | Neuronyx, Inc. | Novel synthetic gangliosides |
| AU2002224444A1 (en) | 2000-10-24 | 2002-05-06 | Children's Hospital Of Philadelphia | Therapeutic uses for mesenchymal stromal cells |
| CA2438501C (en) | 2001-02-14 | 2014-09-16 | Leo T. Furcht | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| US7056738B2 (en) | 2001-03-23 | 2006-06-06 | Tulane University | Early stage multipotential stem cells in colonies of bone marrow stromal cells |
| US20030003090A1 (en) | 2001-05-31 | 2003-01-02 | Prockop Darwin J. | Directed in vitro differentiation of marrow stromal cells into neural cell progenitors |
| US20030059941A1 (en) | 2001-06-14 | 2003-03-27 | Prockop Darwin J. | Transduced marrow stromal cells |
| US20030017587A1 (en) | 2001-07-18 | 2003-01-23 | Rader William C. | Embryonic stem cells, clinical applications and methods for expanding in vitro |
| US9969980B2 (en) | 2001-09-21 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
| US9969977B2 (en) | 2002-09-20 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
| JP2006516134A (ja) * | 2002-12-24 | 2006-06-22 | アン−ゴ−ゲン・インコーポレイテッド | 封入化細胞療法 |
| WO2004072226A2 (en) | 2003-02-13 | 2004-08-26 | Reprocell Inc. | Marker for undifferentiated state of cell and composition and method for separation and preparation of stem cells |
| WO2006050091A2 (en) * | 2004-10-28 | 2006-05-11 | Medivas, Llc | Bioactive wound dressings and implantable devices and methods of use |
| CA2564679C (en) * | 2004-03-22 | 2015-06-23 | Osiris Therapeutics, Inc. | Mesenchymal stem cells and uses therefor |
| CA2566561C (en) * | 2004-06-04 | 2013-01-08 | Universite Pierre Et Marie Curie - Paris Vi | A method for producing red blood cells |
| JP2008501724A (ja) * | 2004-06-11 | 2008-01-24 | ヴィクトリアン ティッシュ エンジニアリング センター プロプライアトリー リミテッド | 組織材料およびマトリックス |
| US8354370B2 (en) | 2007-06-15 | 2013-01-15 | Garnet Biotherapeutics, Inc. | Administering a biological composition or compositions isolated from self-renewing colony forming somatic cell growth medium to treat diseases and disorders |
-
2008
- 2008-06-16 US US12/140,065 patent/US8354370B2/en not_active Expired - Fee Related
- 2008-06-16 WO PCT/US2008/007488 patent/WO2008156728A1/en not_active Ceased
- 2008-06-16 CA CA2690143A patent/CA2690143A1/en not_active Abandoned
- 2008-06-16 KR KR1020107000829A patent/KR20100035648A/ko not_active Withdrawn
- 2008-06-16 JP JP2010512217A patent/JP2010529987A/ja active Pending
- 2008-06-16 EP EP08768506.1A patent/EP2171043B1/en active Active
- 2008-06-16 AU AU2008266885A patent/AU2008266885A1/en not_active Abandoned
- 2008-06-16 EA EA201070022A patent/EA201070022A1/ru unknown
- 2008-06-16 AP AP2010005103A patent/AP2010005103A0/en unknown
- 2008-06-16 NZ NZ582616A patent/NZ582616A/en not_active IP Right Cessation
- 2008-06-16 MX MX2009013672A patent/MX2009013672A/es active IP Right Grant
- 2008-06-16 CN CN200880025039A patent/CN101835891A/zh active Pending
-
2009
- 2009-12-01 IL IL202445A patent/IL202445A0/en unknown
- 2009-12-14 CO CO09142587A patent/CO6251330A2/es not_active Application Discontinuation
-
2012
- 2012-01-12 US US13/349,394 patent/US20120156192A1/en not_active Abandoned
- 2012-01-12 US US13/349,385 patent/US20120148544A1/en not_active Abandoned
-
2013
- 2013-08-19 US US13/970,377 patent/US20140099329A1/en not_active Abandoned
- 2013-08-19 US US13/970,365 patent/US20140086884A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20120148544A1 (en) | 2012-06-14 |
| EP2171043A1 (en) | 2010-04-07 |
| EP2171043A4 (en) | 2010-08-11 |
| US20120156192A1 (en) | 2012-06-21 |
| US20140099329A1 (en) | 2014-04-10 |
| CA2690143A1 (en) | 2008-12-24 |
| AP2010005103A0 (en) | 2010-02-28 |
| EP2171043B1 (en) | 2015-03-18 |
| WO2008156728A1 (en) | 2008-12-24 |
| KR20100035648A (ko) | 2010-04-05 |
| NZ582616A (en) | 2012-07-27 |
| CN101835891A (zh) | 2010-09-15 |
| US20140086884A1 (en) | 2014-03-27 |
| JP2010529987A (ja) | 2010-09-02 |
| US20090053183A1 (en) | 2009-02-26 |
| EA201070022A1 (ru) | 2010-06-30 |
| US8354370B2 (en) | 2013-01-15 |
| MX2009013672A (es) | 2010-03-30 |
| CO6251330A2 (es) | 2011-02-21 |
| IL202445A0 (en) | 2011-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8354370B2 (en) | Administering a biological composition or compositions isolated from self-renewing colony forming somatic cell growth medium to treat diseases and disorders | |
| JP2010529987A5 (cg-RX-API-DMAC7.html) | ||
| JP6966332B2 (ja) | 間葉系幹細胞を含む組成物およびその使用 | |
| JP2013510582A (ja) | 間葉幹細胞の球状集合体 | |
| Cheng et al. | Influence of human platelet lysate on extracellular matrix deposition and cellular characteristics in adipose-derived stem cell sheets | |
| US10709742B2 (en) | Method to amplify cardiac stem cells in vitro and in vivo | |
| TW201130977A (en) | Mesenchymal stem cells (MSCs) isolated from mobilized peripheral blood | |
| US20130259837A1 (en) | Compositions and Methods of Using Living and Non-Living Bioactive Devices with Components Derived From Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro | |
| JP2017104091A (ja) | 間葉系細胞の製造方法 | |
| AU2013202319A1 (en) | Treatment of diseases and disorders using self-renewing colony forming cells cultured and expanded in vitro | |
| HK1143181B (en) | Treatment of diseases and disorders using self-renewing colony forming cells cultured and expanded in vitro | |
| HK1143181A1 (en) | Treatment of disease and dysfunction with self-renewing colony forming cells in vitro | |
| EP4667563A1 (en) | Cell population comprising mesenchymal cells, pharmaceutical composition comprising cell population, exosome obtained from cell population, and method for producing cell population | |
| RU2742034C2 (ru) | Бесклеточные терапевтические средства для регенеративной медицины и способы их получения | |
| CN110840914B (zh) | 细胞治疗剂用于缓解或改善血管病变的方法 | |
| EP4669327A1 (en) | THYMUS REGENERATION PROCESS | |
| HK40084736A (en) | Method for producing proliferating cells, method for producing cell product, mesenchymal stem cell population and method for producing same, culture supernatant of stem cells and method for producing same, and therapeutic agent | |
| Zhang et al. | A novel population of human bone marrow multipotent mesenchymal stem cells regenerates infarcted myocardium in rats |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |